MARCIA, led by researchers from Institute of Sanitary Investigation of Santiago de Compostela (Spain), is one of the supported research teams in the first S3E Start Programme.
Their project aims to obtain a BLOCK test from a blood sample, as a follow-up, non-invasive tool for patients with breast cancer to help diagnose metastasis in an earlier stage. They’re working to develop a tool based on an immunoassay to detect a blood biomarker, and a software with an easy interface that integrates this measurement with two additional blood parameters to assess the risk of metastasis. The target population are women previously diagnosed with a primary breast tumour who are under follow-up (2-5 years from the primary diagnosis).
During this period, an imaging examination (mammogram) is recommended annually. With MARCIA’s product, they’d measure a biomarker which reports systemic tumour disease and two blood parameters at intervals when image analysis is not scheduled. This will allow these patients to be monitored more frequently. If the test is positive, the appointment for the image analysis can be advanced. End-users are healthcare professionals (physicians, nurses and technicians) and potential customers of the kit are health systems, public and private clinics and hospitals. The beneficiaries are patients diagnosed with breast cancer, of which about 30% will eventually develop metastases. Furthermore, oncologists will benefit indirectly by having a tool to improve clinical management. The ability to anticipate this progression is crucial for the patient (quality and life expectancy) and the system (savings).
Learn more about MARCIA by watching the pitch done by researcher Clotilde Costa during the Start Open Day on 20th July 2023.
Would you like to get in touch with them? Let us know! Email us at info@south3e.eu